Shared Savings Programs in Europe
Lessons for the United States
Acceptance and use of biosimilars has been rising in the U.S. Biosimilars can enhance the sustainability of the overall healthcare system through savings and increased access. Currently, there are policies under discussion in the U.S. to improve access to biosimilars, and some of these policies include shared savings programs (also known as benefit sharing or gain sharing in other countries). Shared savings programs have been implemented in a number of countries in Europe. While contexts across countries vary, the experience of such programs in other countries can provide lessons for the U.S.
In this report, five case studies of shared savings/benefit sharing programs from across Europe are examined using secondary research, expert interviews and IQVIA data. The background to setting up a program is provided for each case study along with the structure of the program and results as stated in secondary literature and as per IQVIA data. Lessons for the U.S. are summarized based on these case studies.